Michael John Dickinson

57PUBLICATIONS
294CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursSolid tumoursChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Nov 10, 2026
CD19-CD28 costimulatory bispecific antibody plus glofitamab in R/R B-NHL: a phase 1 dose-escalation study.

|Sep 30, 2026
Preventing infections after CD19-directed chimeric antigen receptor T-cell therapies for lymphoma: a consensus practice statement.

|Sep 07, 2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

|Sep 02, 2026
CAR transgenic T-cell lymphoproliferative neoplasm: malignant transformation of cellular immunotherapy.

|Aug 21, 2026
Rewiring immunity with in vivo CAR T cell engineering.

|Aug 17, 2026
Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study.

Pageof 10

Frequent Collaborators

10 joint publications

Chan Y Cheah

9 joint publications

Nada Hamad

8 joint publications

Adrian Minson

8 joint publications

Matthew Ku